[go: up one dir, main page]

DK1411992T3 - Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics - Google Patents

Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics

Info

Publication number
DK1411992T3
DK1411992T3 DK02758379T DK02758379T DK1411992T3 DK 1411992 T3 DK1411992 T3 DK 1411992T3 DK 02758379 T DK02758379 T DK 02758379T DK 02758379 T DK02758379 T DK 02758379T DK 1411992 T3 DK1411992 T3 DK 1411992T3
Authority
DK
Denmark
Prior art keywords
ionic
ray
combined
magnetic resonance
nuclear magnetic
Prior art date
Application number
DK02758379T
Other languages
Danish (da)
Inventor
Silvio Aime
Alessandro Barge
Valentina Mainero
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Application granted granted Critical
Publication of DK1411992T3 publication Critical patent/DK1411992T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

The invention discloses the use of ionic and non-ionic radiographic contrast agents for combined X-ray and nuclear magnetic resonance (MRI) diagnostics.
DK02758379T 2001-08-03 2002-07-23 Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics DK1411992T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001706A ITMI20011706A1 (en) 2001-08-03 2001-08-03 IONIC AND NON-IONIC RADIOGRAPHIC CONTRAST AGENTS, USABLE FOR THE COMBINED DIAGNOSTIC INVESTIGATION THROUGH X-RAYS AND MAGNETIC RESONANCE
PCT/EP2002/008183 WO2003013616A1 (en) 2001-08-03 2002-07-23 Ionic and non-ionic radiographic contrast agents for use in combined x-ray and nuclear magnetic resonance diagnostics

Publications (1)

Publication Number Publication Date
DK1411992T3 true DK1411992T3 (en) 2007-04-10

Family

ID=11448229

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02758379T DK1411992T3 (en) 2001-08-03 2002-07-23 Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics

Country Status (9)

Country Link
US (1) US8211404B2 (en)
EP (1) EP1411992B1 (en)
JP (1) JP4310187B2 (en)
AT (1) ATE347912T1 (en)
DE (1) DE60216770T2 (en)
DK (1) DK1411992T3 (en)
ES (1) ES2278946T3 (en)
IT (1) ITMI20011706A1 (en)
WO (1) WO2003013616A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070015517A (en) 2004-03-11 2007-02-05 말린크로트, 인코포레이티드 VIII-contrast formulation comprising a mixture of iodinated monomers and dimers
DE102005028882A1 (en) * 2005-06-22 2007-01-04 Siemens Ag A solution and method for assisting imaging on a patient
CN101356447B (en) * 2005-07-21 2012-06-27 约翰斯霍普金斯大学 Non-invasive MRI measurement of tissue glycogen
EP2073723A4 (en) * 2006-10-10 2011-03-30 Mayo Foundation REDUCTION OF TOXICITY INDUCED BY A CONTRAST AGENT
WO2009047316A1 (en) * 2007-10-12 2009-04-16 Ge Healthcare As Contrast agents
JP2011504939A (en) * 2007-11-07 2011-02-17 ジーイー・ヘルスケア・アクスイェ・セルスカプ Contrast agent
DE102007058220A1 (en) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft New metal complexes useful e.g. for manufacturing agent for X-ray diagnostics and magnetic resonance tomography-diagnostics of brain infarcts and liver tumor, and/or space-process in liver and abdomen tumors and musculoskeletal tumors
JP2011506286A (en) * 2007-12-05 2011-03-03 ジーイー・ヘルスケア・アクスイェ・セルスカプ Contrast agent
EP2245003A2 (en) * 2008-02-27 2010-11-03 GE Healthcare AS Contrast agents
EP2243767A1 (en) 2009-04-21 2010-10-27 Bracco Imaging S.p.A Process for the iodination of aromatic compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541272A1 (en) * 1983-02-23 1984-08-24 Guerbet Sa BROMINE COMPOUNDS AND OPACIFIER PRODUCTS CONTAINING THEM
CA2187427A1 (en) 1995-02-24 1996-08-29 Herve Tournier Liposome suspensions as blood pool imaging contrast agents
US5648536A (en) * 1995-06-07 1997-07-15 Dunn; Thomas Jeffrey Process for producing ioversol
CN1221250C (en) 1998-04-09 2005-10-05 阿莫萨姆保健公司 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
AU4656400A (en) * 1999-04-21 2000-11-17 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Method for enhancing contrast produced by mri
FR2794744B1 (en) * 1999-06-09 2001-09-21 Guerbet Sa METAL COMPLEXES OF BICYCLIC POLYAMINOACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN MEDICAL IMAGING

Also Published As

Publication number Publication date
JP4310187B2 (en) 2009-08-05
JP2005505527A (en) 2005-02-24
ITMI20011706A0 (en) 2001-08-03
EP1411992A1 (en) 2004-04-28
US8211404B2 (en) 2012-07-03
ATE347912T1 (en) 2007-01-15
ITMI20011706A1 (en) 2003-02-03
DE60216770T2 (en) 2007-04-12
US20050113675A1 (en) 2005-05-26
EP1411992B1 (en) 2006-12-13
DE60216770D1 (en) 2007-01-25
ES2278946T3 (en) 2007-08-16
WO2003013616A1 (en) 2003-02-20
WO2003013616A8 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
NO991688D0 (en) Manageable compositions and methods for magnetic resonance imaging
DE69829820D1 (en) Examination table, in particular for nuclear magnetic resonance imaging systems
AU2002367581A8 (en) Three-frequency nuclear quadrupole resonance (nqr)
TW200512006A (en) A method for making a magnetic resonance (MR) imaging agent, a mr imaging contrast agent, a metnod for altering stability of a peptide and a modified peptide
DE60144174D1 (en) Radiography system for radiation images
DE60222933D1 (en) PATIENT STORAGE DEVICE FOR A MEDICAL IMAGING SYSTEM WITH DIFFERENT OPERATING MODES
DK1411992T3 (en) Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics
IS2127B (en) Metallic constituents containing perfluoroalkyl and their use in magnetic resonance imaging
DK1404873T3 (en) CHEMICAL IMMUNO MODULATOR RELATIONS AND PROCEDURES FOR USE THEREOF
WO2002017789A3 (en) Methods and devices for quantitative analysis of x-ray images
DK1183255T3 (en) Metal complexes of bicyclic polyamino acids, processes for their preparation and their use for medical imaging
DK2298362T3 (en) Reactive paramagnetic contrast agents for magnetic resonance imaging techniques
ITMI20011708A0 (en) CONJUGATES OF PEPTIDES, THEIR DERIVATIVES WITH METAL COMPLEXES AND USE FOR DIAGNOSTIC INVESTIGATION THROUGH MAGNETIC RESONANCE IMAGING (M
DE69230400D1 (en) Contrast medium
NL1005396A1 (en) MR (magnetic resonance) imaging device.
NO963381D0 (en) Contrast agents e.g. for use in ultrasound imaging
ES2117670T3 (en) DERIVED FROM HYDROXAMATE AND HYDRAZIDE OF POLYAMINS AND THEIR MEDICAL USE AS CHELATING AGENTS.
NO940115D0 (en) Contrast agents for X-ray and magnetic tomographic imaging
DE602005018035D1 (en) MAGNETIC STRUCTURE FOR AN MRI DEVICE AND MRI DEVICE
BR9508435A (en) Macrocyclic chelates and their chelates and their uses in the diagnostic field
WO2003084384A3 (en) Diagnosis of flavivirus infection
MXPA03001287A (en) Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses.
IL159479A0 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
DK1418905T3 (en) Therapeutic agent for depleting an unwanted plasma protein population
IL165889A0 (en) Use of metal complexes containing perfluoroalkyl as contrast agents in magnetis resonance imaging for representing imtravascular thrombi